Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold

August 3, 2012 3:03 PM EDT
Get Alerts UTHR Hot Sheet
Price: $154.26 -0.8%

Rating Summary:
    7 Buy, 12 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 1 | Down: 0 | New: 0
Trade UTHR Now!
Join SI Premium – FREE
Standpoint Research downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Hold.

The firm comments, "Our March 12 recommendation UTHR has jumped 40% since April 18 and just hit a 52-week high. The shares have out-performed the S&P-500 by more than 1500 bps since our recommendation. We can no longer leave our highest recommendation attached to this name. Our price target for 2013-2014 remains $60-$65."

For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.

Shares of United Therapeutics Corp. closed at $53.75 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Standard & Poor's, Standpoint Research

Add Your Comment